戻る Agenda
LS49 Introduction for DIA Japan Community
Session Chair(s)
Kazuhiko Ishida, MSc, RPh
Director, Pharmacovigilance, Astellas Pharma Inc., Japan
Speaker(s)
Tomohiko Takahashi
Associate Manager, Headquarters of Clinical Development, Otsuka Pharmaceutical Co., Ltd., Japan
So Miyoshi
Head of Clinical Pharmacology & Bioanalytics, Pfizer R&D Japan, Japan
Yoshiyuki Sugimoto, PhD, RPh
Associate Director, Argenx Japan, Japan
Keiko Katsui, PhD
Manager, Division of Biomedical Ethics and Social Co-Creation, Japan Agency for Medical Research and Development (AMED), Japan
Noriaki Nagao, MPharm, PMP
, The Cancer Institute Hospital Of JFCR, Japan
Kanji Hirai, RPh
Director, Regulatory Policy & Intelligence, Regulatory Affair Area, Japan Dvlpmt, MSD K.K., Japan
Taro Amagasaki, PhD
Head, Analytics Japan, Novartis Pharma K.K., Japan
Kotone Matsuyama, RPh
Center for Clinical Research and Development, National Center for Child Health and Development, Japan